Since the introduction of domestic antivenom in the 1970s and 1980s, with the improvement of medical conditions in China after the reform and opening up, it has basically achieved popularization from the 1990s to the first few years of the 21st century. However, with the establishment of the socialist market economy and the completion of the medical and health reforms, the supply of antivenoms, which were originally sufficient, began to be in short supply. In order to solve the supply problem of shortage drugs such as antivenom, the national and local health authorities have carried out beneficial explorations to establish a shortage drug guarantee mechanism. The academic circle has also restarted the research on traditional Chinese medicine snakebite preparations and antivenoms that have been completed in the 20th century, and has been establishing provincial and municipal snakebite treatment centers and cross-regional snakebite treatment bases, conducting international snakebite treatment and making research collaborations to actively respond to the current shortage of antivenoms.Since entering the 21st century, the problem of poisonous snakebite has retreated in a secondary position in the medical community, and the research on progress in this area has basically no longer attracted the attention of the academic community. In fact, the tension of contemporary snake bite medical resources is not only domestic, but also showing a stronger status quo in the world, and is becoming a medical problem that cannot be ignored. This article uses the time-delayed research method, systematically combing the repeated fluctuations of anti -snake -toxic serum supply before 2000 to these years, as well as the relevant historical facts of the re-development and application of drugs such as traditional Chinese medicine snakebite preparations for alternatives. The attention of the academic and relevant departments attracted the attention of this issue, and the early prevention of snake bite in order to take into account the "green water and green mountains"policy and ensure the health of the people's lives are hoped to be taken.
Published in | Science Discovery (Volume 11, Issue 5) |
DOI | 10.11648/j.sd.20231105.11 |
Page(s) | 175-182 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2023. Published by Science Publishing Group |
Antivenom, Traditional Chinese Medicine Snakebite Preparations, Shortage of Drugs Guarantee, Traditional Chinese Medicine
[1] | 白剑峰.医改带来了什么 [J]. 慢性病学杂志, 2001 (2): 37-38. |
[2] | 欧阳向华, 卢德文, 周宁, 等. 常见毒蛇咬伤早期中毒的快速诊治 [J]. 现代医院, 2008, 8 (4): 53-54. |
[3] | 佚名. 中国医改发展报告2009~2014 [M]. 中国协和医科大学出版社, 2015: 79. |
[4] | 朱幼棣. 招标采购未解决重要问题 [J]. 中国医院院长, 2011 (12): 1. |
[5] | 席晓宇, 陈聪, 褚淑贞. 国家处方集中基本药物使用情况对比研究 [J]. 药品评价, 2011, 8 (16): 4. |
[6] | 孔绶蘅. 毒蛇及狂犬咬伤中毒方 [J]. 上海中医药杂志, 1956 (9): 35. |
[7] | 武汉一女子被五步蛇咬伤 急飞广州注射血清救命 [N]. 楚天都市报, 2010-01-26 (1). |
[8] | 全国蛇伤者剧增市中医院抗蝮蛇毒血清紧缺 [N]. 都市快报, 2010-07-23 (1). |
[9] | 蛇伤救治 “浙江模式”: 或可率先实现浙江蛇伤救治 “零死亡率”, 实现单病种浙江省年度零死亡率 [EB/OL]. 好大夫在线, 2019-10-26. https:www.haodf.com/neirongwenzhang/8064651649.html. |
[10] | 抗蛇毒血清长沙告急 [N]. 长沙晚报, 2010-07-29 (1). |
[11] | 全国抗蛇毒血清告急 北京仅一医院存抗毒血清 [N]. 新京报, 2010-10-19 (1). |
[12] | 湘西州抗蛇毒血清短缺之困亟待破解 [N]. 团结报, 2014-03-30 (1). |
[13] | 佚名. 国家食品药品监管局核实抗蛇毒血清供应情况 [J]. 世界临床药物, 2012, 33 (9): 1. |
[14] | 没抗蛇毒血清, 伤不起 [N]. 广东科技报, 2011-09-17 (4). |
[15] | 抗蛇毒血清短缺之困如何解 [N]. 中国医药报, 2013-04-23 (7). |
[16] | 汪国和. 特殊情况下应用过期抗蛇毒血清的体会 [J]. 蛇志, 1994, 6 (1): 1. |
[17] | 救命血清一剂难求, 背后是 “市场失灵” [N]. 新京报, 2014-08-21 (1). |
[18] | 毒蛇频出没救命血清短缺 业内: 成本高但医保报价低 [EB/OL]. 央广网 (搜狐网), 2016-08-09. https:www.sohu.com/a/109755457_362103. |
[19] | 20支抗蛇毒血清连夜调往南京六合, 卫计局发布中毒急救办法 [EB/OL]. 澎湃新闻, 2016-10-11. https:www.thepaper.cn/news/Detail_forward_/1541509. |
[20] | 江苏统一廉价短缺药价格 [N]. 江苏法制报, 2012-07-18 (A01). |
[21] | 江苏短缺药有望省内定点生产 宁徐淮泰四城还要建 “仓库” [N]. 现代快报, 2013-01-17 (1). |
[22] | 江苏推行廉价短缺药价格保护机制 [N]. 江南保健报, 2013-04-25 (A21). |
[23] | 短缺药储备江苏发力 定价仍是难题 [N]. 医药经济报, 2013-08-21 (A01). |
[24] | 江苏新增17种短缺救命药 [N]. 扬子晚报, 2015-04-16 (A06). |
[25] | 江苏今年完善省级短缺药储备制度 [N]. 金陵晚报, 2015-01-28 (A04). |
[26] | 本月起, 江苏建立短缺药信息 “零报告” 制度 [N]. 金陵晚报, 2017-08-03 (B01). |
[27] | 低价药将取消最高零售限价 对市场供应短缺药品试点国家统一定价 [N]. 乌鲁木齐晚报, 2014-04-16 (10). |
[28] | 李木元. 国家取消低价药最高零售限价6月底前启动短缺药品招标定点生产 [N]. 人民政协报, 2014-04-23 (4). |
[29] | 国家药典委员会编.中华人民共和国药典 (2015年版) 三部 [M]. 北京: 中国医药科技出版社, 2015: 224-238. |
[30] | 中办国办转发 «国务院深化医药卫生体制改革领导小组关于进一步推广深化医药卫生体制改革经验的若干意见» [EB/OL]. 新华社, 2016-11-08. http:www.xinhuanet.com/politics/2016-1108c_1/119875054.htm. |
[31] | 关于改革完善短缺药品供应保障机制的实施意见 [EB/OL]. 新华社, 06-29-2017. http:www.gov.cn/xinwen2017-06-29/content_/5206573.htm. |
[32] | 赛伦生物IPO: 上生所技术出资估值过低生讼, 突击大额分红 [EB/OL]. 凤凰网, 2021-08-05. http:ishare.ifeng.com/csv002h-_3nd/MYObqXecPl1oV1YFUFqOdJSxG5nyTg20MeC7SE__. |
[33] | 赛伦生物二闯科创板: 稀有核心品种抗蛇毒血清, 产品提价乏力令业绩低迷 [EB/OL]. 腾讯闻, 2021-08-09. http:view.inews.qq.com/a/20210809A0FSZL00/startextras=undefined&from=ampzkqw. |
[34] | 滕昶.抗蛇毒血清空前紧缺 [J]. 时代周报, 2012 (35): 13-17. |
[35] | 王家庭. 快速城市化时期中国城市蔓延的理论与实证研究 [M]. 北京: 人民出版社, 2020:238. |
[36] | 2021年我国抗血清抗毒素领域药物行业相关政策汇总 [EB/OL] 观研报告网, 2021-10-09. http:zhengce.chinabaogao.com/yiyao202110955564H021.html. |
[37] | 陈玉辉. 丹参酮IIA磺酸钠注射液佐治蝮蛇咬伤35例疗效观察 [J]. 蛇志, 2008, 20 (4): 1. |
[38] | Kumar P, Clark M L., Kumar and Clark's Clinical Medicine [J]. British Journal of Hospital Medicine, 2012: 269-282. |
[39] | 顾海琳. 复方丹参注射液治疗蝮蛇咬伤的临床观察 [J]. 长春中医药大学学报, 2000 (4): 23-24. |
[40] | 史海燕. 丹参注射液治疗蝮蛇咬伤伤肢肿胀疗效观察 [J]. 蛇志, 2004 (4): 29. |
[41] | 汤启助. 复方丹参注射液临床应用中不良反应观察 [J]. 中国中药杂志, 1999, 24 (1): 57-59. |
[42] | 郑颖, 范泉水, 张连江, et al. 我国主要致伤的9种陆生毒蛇抗血清间的交叉免疫中和效价测定 [C]. 第八届中国生物毒素学术研讨会编印, 2007: 37. |
[43] | 王世军, 黄小宾, 江山, 等. 三草汤在蛇患者者中抗肾损害的临床研究 [J]. 蛇志, 2010 (3): 2. |
[44] | 何少华. 中西医结合治疗326例青竹蛇患者者的疗效观察 [J]. 蛇志, 2011, 23 (1): 2. |
[45] | 刘乐灵. 中医药治疗毒蛇咬伤系列研究中国, 9352017Y0054.1 [P]. 2017-11-22. |
[46] | 孙涛. 国医年鉴 (2018卷) [M]. 中医古籍出版社, 2018: 92. |
[47] | 谢灿茂. 内科急症治疗学 (第6版) [M]. 上海: 上海科学技术出版社, 2017: 598. |
[48] | Schade R, Staak C, Hendriksen C, et al. The production of avian (egg yolk) antibodiesIgY. The report and rec-ommendations of ECVAM workshop 21 [J]. ATLA, 1997, 24 (6): 925-934. |
[49] | 孔天翰, 刘四红. 抗眼镜蛇毒鸡卵黄抗体研究 [C]. 第八届中国生物毒素学术研讨会. 2007: 43. |
[50] | 潘泓, 陈程, 詹迪深, 等.抗中华眼镜蛇毒鸡卵黄抗体IgY的动物保护作用研究 [J]. 蛇志, 2009 (2): 5. |
[51] | 祁俊华. 双价抗蛇毒鸡卵黄抗体的制备及其特性研究 [D]. 博士论文. 广州医学院, 2009. |
[52] | 覃燕秋, 梁歆敏, 唐佩玲, 等. 蛇咬伤的下一代救治方法--生物合成寡克隆抗蛇毒血清 [J]. 蛇志, 2019, 31 (3): 3. |
[53] | 劳伯勋编. 中国养蛇学 [M]. 合肥: 安徽科学技术出版社, 2011: 422. |
[54] | 郑颖, 余方芳, 范泉水, 等. 抗金环蛇毒血清生产工艺的研究 [J]. 蛇志, 2007, 19 (3): 4. |
[55] | 张连江, 郑颖, 范泉水, 等. 精制抗眼镜王蛇毒血清的制备 [J]. 中国药学杂志, 2008, 43 (5): 5. |
[56] | 范泉水, 郑颖, 张连江, 等. 新型精制抗蛇毒血清的制备 [J]. 蛇志, 2007, 19 (1): 3. |
[57] | 福建省卫生健康委员会关于省政协十二届三次会议20202065号提案的答复 [EB/OL]. 福建省卫生健康委员会官网, 2020-07-17. http:wjw.fujian.gov.cn/xxgkfgwjzxwj202007t20200720_5326476.htm. |
[58] | 闽粤赣边蛇伤救治基地 [EB/OL]. 2015-12-16, https:baike.baidu.com/item%E9%97%BD%E7%B2%A4%E8%B5%A3%E8%BE%B9%E8%9B%87%E4%BC%A4%E6%95%91%E6%B2%BB%E5%9F%BA%E5%9C%B019148991fr=aladdin. |
[59] | 丽水市中心医院蛇伤救治中心成立 [EB/OL]. 浙江卫生计生, 2015-07-01. http:www.lshospital.zj.cn/ArticleHTML6328.html. |
[60] | 蛇伤不小觑 救治需规范——浙江省蛇伤规范化救治研讨会暨蛇伤救治公益培训班 (松阳站) 开班 [EB/OL]. 浙江省中医院, 2019-08-01. http:www.zjhTCM.com/xsArtArt_19Art_19_1338.aspx. |
[61] | 去年救治蛇伤病人501例! 肇庆蛇医专家收四名承继人 [N]. 西江日报, 2016-12-21 (1). |
[62] | 佚名. 中国蛇伤走向世界——肇庆市蛇伤救治基地, 肇庆市第三人民医院, 广东省中西医结合学会蛇伤急救网点医院[C]. 2014: 131-136. |
[63] | 近期多人被蛇咬伤! 专家提醒, 被蛇咬伤务必4小时内就医 [N]. 广州日报, 2021-04-21 (1). |
[64] | 谢锐光, 余培南, 钟汉, 等. 毒蛇咬伤重, 危症诊断中西医评分标准的研究 [C]. 全国中西医结合疡科学术交流会. 2009: 133-138. |
[65] | 李环羽. 广西蛇伤救治中心揭牌成立 [J]. 蛇志, 2018, 30 (3): 180. |
[66] | 李环羽. 全国多地成立蛇伤救治中心 [J]. 蛇志. 2021 (2): 250. |
[67] | 林起庆, 宋丽, 王威, 李其斌.蛇伤防治三级管理体系建设的探讨 [J]. 蛇志, 2020, 32 (4): 397-399. |
[68] | 陈丽阳, 许钊虹, 曾潭飞, 等. 澳门毒蛇咬伤的现状与急诊救治分析 [J]. 临床医药文献电子杂志, 2016, 3 (44): 2. |
[69] | 郑晓文. 第一届中国—东盟急诊医学国际高峰论坛在南宁成功召开 [J]. 蛇志, 2016, 28 (4): 1. |
[70] | 李环羽. 第二届中国—东盟急诊医学国际高峰论坛在南宁成功举办 [J]. 蛇志, 2017, 29 (4): 180. |
[71] | 李环羽. 第三届中国—东盟急诊医学国际论坛开幕 [J]. 蛇志, 2018, 30 (4): 219. |
[72] | 李环羽. 广西医科大学牵头成立中国蛇伤救治联盟并举行揭牌仪式 [J]. 蛇志, 2018, 30 (4): 220. |
APA Style
Wei-ren, S. (2023). Antivenom Shortage in the Early 21st Century and Its Countermeasures. Science Discovery, 11(5), 175-182. https://doi.org/10.11648/j.sd.20231105.11
ACS Style
Wei-ren, S. Antivenom Shortage in the Early 21st Century and Its Countermeasures. Sci. Discov. 2023, 11(5), 175-182. doi: 10.11648/j.sd.20231105.11
@article{10.11648/j.sd.20231105.11, author = {Shi Wei-ren}, title = {Antivenom Shortage in the Early 21st Century and Its Countermeasures}, journal = {Science Discovery}, volume = {11}, number = {5}, pages = {175-182}, doi = {10.11648/j.sd.20231105.11}, url = {https://doi.org/10.11648/j.sd.20231105.11}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sd.20231105.11}, abstract = {Since the introduction of domestic antivenom in the 1970s and 1980s, with the improvement of medical conditions in China after the reform and opening up, it has basically achieved popularization from the 1990s to the first few years of the 21st century. However, with the establishment of the socialist market economy and the completion of the medical and health reforms, the supply of antivenoms, which were originally sufficient, began to be in short supply. In order to solve the supply problem of shortage drugs such as antivenom, the national and local health authorities have carried out beneficial explorations to establish a shortage drug guarantee mechanism. The academic circle has also restarted the research on traditional Chinese medicine snakebite preparations and antivenoms that have been completed in the 20th century, and has been establishing provincial and municipal snakebite treatment centers and cross-regional snakebite treatment bases, conducting international snakebite treatment and making research collaborations to actively respond to the current shortage of antivenoms.Since entering the 21st century, the problem of poisonous snakebite has retreated in a secondary position in the medical community, and the research on progress in this area has basically no longer attracted the attention of the academic community. In fact, the tension of contemporary snake bite medical resources is not only domestic, but also showing a stronger status quo in the world, and is becoming a medical problem that cannot be ignored. This article uses the time-delayed research method, systematically combing the repeated fluctuations of anti -snake -toxic serum supply before 2000 to these years, as well as the relevant historical facts of the re-development and application of drugs such as traditional Chinese medicine snakebite preparations for alternatives. The attention of the academic and relevant departments attracted the attention of this issue, and the early prevention of snake bite in order to take into account the "green water and green mountains"policy and ensure the health of the people's lives are hoped to be taken.}, year = {2023} }
TY - JOUR T1 - Antivenom Shortage in the Early 21st Century and Its Countermeasures AU - Shi Wei-ren Y1 - 2023/09/27 PY - 2023 N1 - https://doi.org/10.11648/j.sd.20231105.11 DO - 10.11648/j.sd.20231105.11 T2 - Science Discovery JF - Science Discovery JO - Science Discovery SP - 175 EP - 182 PB - Science Publishing Group SN - 2331-0650 UR - https://doi.org/10.11648/j.sd.20231105.11 AB - Since the introduction of domestic antivenom in the 1970s and 1980s, with the improvement of medical conditions in China after the reform and opening up, it has basically achieved popularization from the 1990s to the first few years of the 21st century. However, with the establishment of the socialist market economy and the completion of the medical and health reforms, the supply of antivenoms, which were originally sufficient, began to be in short supply. In order to solve the supply problem of shortage drugs such as antivenom, the national and local health authorities have carried out beneficial explorations to establish a shortage drug guarantee mechanism. The academic circle has also restarted the research on traditional Chinese medicine snakebite preparations and antivenoms that have been completed in the 20th century, and has been establishing provincial and municipal snakebite treatment centers and cross-regional snakebite treatment bases, conducting international snakebite treatment and making research collaborations to actively respond to the current shortage of antivenoms.Since entering the 21st century, the problem of poisonous snakebite has retreated in a secondary position in the medical community, and the research on progress in this area has basically no longer attracted the attention of the academic community. In fact, the tension of contemporary snake bite medical resources is not only domestic, but also showing a stronger status quo in the world, and is becoming a medical problem that cannot be ignored. This article uses the time-delayed research method, systematically combing the repeated fluctuations of anti -snake -toxic serum supply before 2000 to these years, as well as the relevant historical facts of the re-development and application of drugs such as traditional Chinese medicine snakebite preparations for alternatives. The attention of the academic and relevant departments attracted the attention of this issue, and the early prevention of snake bite in order to take into account the "green water and green mountains"policy and ensure the health of the people's lives are hoped to be taken. VL - 11 IS - 5 ER -